Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 1, 2009, Pages 258-266

  Trivedi, Hariprasad ^a,b   Xiang, Qun ^a   Klein, John P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE   (United States)

Author keywords

Cardiac death; End stage renal disease; Epidemiology; Myocardial infarction; Risk factors

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART DEATH; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; FEMALE; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RENAL DIALYSIS; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 58049219009     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn426     Document Type: Article

References (37)

1. USRDS. 2007 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA, 2007
2. USRDS. 2004 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA, 2004
3. Raine AE, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl 2): 7-35
4. Herzog CA, Ma ZA, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805
5. United States Renal Data System, Researcher's Guide to the USRDS Database. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA, 2006
6. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data, 2nd edn. New York: Springer, 2003
7. Klein JP, Wu JT. Discretizing a continuous covariate in survival studies. In: Balakrishnan N, Rao CR (eds). Handbook of Statistics, 23: Advances in Survival Analysis. Amsterdam, The Netherlands: Elsevier, 2004, 27-42
8. Rocco MV, Yan G, Gassman J et al. Comparison of causes of death using HEMO study and HCFA end-stage renal disease death notification classification systems. Am J Kidney Dis 2002; 39: 146-153
9. Shepherd J, Cobbe SM, Ford I et al. (for the West of Scotland Coronary Prevention Study Group). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307
10. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 8934: 1383-1389
11. Pugh JA, Tuley MR, Basu S. Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis 1994; 23: 803-807
12. Bloembergen WE, Port FK, Mauger EA et al. Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol 1994; 5: 1231-1242
13. Wong JS, Port FK, Hulbert-Shearon TE et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55: 2515-2523
14. Robinson BM, Joffe MM, Pisoni RL et al. Revisiting survival differences by race and ethnicity among hemodialysis patients: the dialysis outcomes and practice patterns study. J Am Soc Nephrol 2006; 17: 2910-2918
15. Price DA, Owen WF Jr. African-Americans on maintenance hemodialysis: a review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther 1997; 4: 3-12
16. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ et al. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 2005; 45: 811-817
17. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-2571
18. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297
19. Agrawal R. Hypertension and survival in chronic hemodialysis patients - past lesions and future opportunities. Kidney Int 2005; 67: 1-13
20. Salem M. Hypertension in the hemodialysis population? High time for answers. Am J Kidney Dis 1999; 33: 592-594
21. Collins AJ, Li S, St Peter W et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 2001; 12: 2465-2473
22. Ma JZ, Ebben J, Xia H et al. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619
23. Regidor DL, Kopple JD, Kovesdy CP et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191
24. Tanaka Y, Joki N, Hase H. History of acute coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating haemodialysis. Nephrol Dial Transplant 2007; 22: 2917-2923
25. Besarab A, Bolton WK, Brown JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
26. Singh AK, Szczech L, Tang KL et al. (for the CHOIR Investigators). Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 335: 2085-2098
27. Macdougall IC, Eckardt K-U, Locatelli F. Latest US KDOQI Anaemia Guidelines update - what are the implications for Europe? Nephrol Dial Transplant 2007; 22: 2738-2742
28. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44: 115-119
29. Avram MM, Mittman N, Bonomini L et al. Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis 1995; 26: 209-219
30. Leavey SF, Strawderman RL, Jones CA et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 1998; 31: 997-1006
31. Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int 2003; 84(Suppl): S94-S97
32. Cano NJM, Fouque D, Roth H et al. (the French Study Group for Nutrition in Dialysis). Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 18: 2583-2591
33. Fink JC, Burdick RA, Kurth SJ et al. Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 1999; 34: 694-701
34. Kalantar-Zadeh K, Block G, Humphreys MH et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808
35. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005; 489-500
36. Longenecker JC, Coresh J, Klag MJ et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. J Am Soc Nephrol 2000; 11: 520-529
37. USRDS. 2005 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA, 2005